Showing results (141-150 of 163) with videos related to
Sort By:
Pageof 17
Journal of Enzyme Inhibition and Medicinal Chemistry|July 25, 2022
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluationMohammed S Taghour, Hazem A Mahdy, Maher H Gomaa, et al.Plos One|September 4, 2025
A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapyIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.Molecules (Basel, Switzerland)|August 12, 2022
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative EvaluationAlaa Elwan, Abdallah E Abdallah, Hazem A Mahdy, et al.Future Medicinal Chemistry|July 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulationsHazem A Mahdy, Hazem Elkady, Mohammed S Taghour, et al.Plos One|January 30, 2023
New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studiesAhmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 17, 2022
New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studiesEslam B Elkaeed, Mohammed S Taghour, Hazem A Mahdy, et al.RSC Advances|August 7, 2023
Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2Souad A El-Metwally, Hazem Elkady, Mohamed Hagras, et al.Bioorganic Chemistry|December 9, 2019
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducersHazem A Mahdy, Mohammed K Ibrahim, Ahmed M Metwaly, et al.Molecules (Basel, Switzerland)|October 14, 2022
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation StudiesEslam B Elkaeed, Reda G Yousef, Mohamed M Khalifa, et al.Journal of Biomolecular Structure & Dynamics|June 1, 2023
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluationsMohammed A Dahab, Hazem A Mahdy, Hazem Elkady, et al.Pageof 17